Review article: the burden of hepatic encephalopathy von POORDAD, F. F.

Volltext

Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents von Poordad, F., Dieterich, D.

Volltext

Interferon-free, direct-acting antiviral therapy for chronic hepatitis C von Gutierrez, J. A., Lawitz, E. J., Poordad, F.

Volltext

Review article: thrombocytopenia in chronic liver disease von POORDAD, F.

Volltext

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR... von Lawitz, Eric, Prof, Poordad, Fred F, Prof, Pang, Phillip S, MD, Hyland, Robert H, DPhil, Ding, Xiao, PhD, Mo, Hongmei, PhD, Symonds, William T, PharmD, McHutchison, John G, MD, Membreno, Fernando E, MD

Volltext

Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy von Mullen, Kevin D, Sanyal, Arun J, Bass, Nathan M, Poordad, Fred F, Sheikh, Muhammad Y, Frederick, R. Todd, Bortey, Enoch, Forbes, William P

Volltext

Hepatitis C infection and the patient with end-stage renal disease von Fabrizi, Fabrizio, Poordad, F.Fred, Martin, Paul

Volltext

Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C von POORDAD, F. F.

Volltext

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, doubl... von Lawitz, Eric, Prof, Lalezari, Jay P, MD, Hassanein, Tarek, Prof, Kowdley, Kris V, Prof, Poordad, Fred F, Prof, Sheikh, Aasim M, MBBS, Afdhal, Nezam H, Prof, Bernstein, David E, Prof, DeJesus, Edwin, MD, Freilich, Bradley, MD, Nelson, David R, Prof, Dieterich, Douglas T, Prof, Jacobson, Ira M, Prof, Jensen, Donald, Prof, Abrams, Gary A, MD, Darling, Jama M, MD, Rodriguez-Torres, Maribel, MD, Reddy, K Rajender, Prof, Sulkowski, Mark S, Prof, Bzowej, Natalie H, MD, Hyland, Robert H, DPhil, Mo, Hongmei, PhD, Lin, Ming, PhD, Mader, Michael, MS, Hindes, Robert, MD, Albanis, Efsevia, MD, Symonds, William T, PharmD, Berrey, Michelle M, MD, Muir, Andrew, Prof

Volltext

Rapid Virologic Response: A New Milestone in the Management of Chronic Hepatitis C von Poordad, Fred, Reddy, K. Rajender, Martin, Paul

Volltext

Review article: diagnosis and treatment of non‐alcoholic fatty liver disease von OH, M. K., WINN, J., POORDAD, F.

Volltext

Hepatitis C Virus Treatment-Related Anemia Is Associated With Higher Sustained Virologic Response Rate von Sulkowski, Mark S, Shiffman, Mitchell L, Afdhal, Nezam H, Reddy, K. Rajender, McCone, Jonathan, Lee, William M, Herrine, Steven K, Harrison, Stephen A, Poordad, F. Fred, Koury, Kenneth, Deng, Weiping, Noviello, Stephanie, Pedicone, Lisa D, Brass, Clifford A, Albrecht, Janice K, McHutchison, John G

Volltext

Randomised clinical trial: rifaximin improves health‐related quality of life in cirrhotic patients with hepatic encephalopathy – a double‐blind placebo‐controlled study von Sanyal, A., Younossi, Z. M., Bass, N. M., Mullen, K. D., Poordad, F., Brown, R. S., Vemuru, R. P., Mazen Jamal, M., Huang, S., Merchant, K., Bortey, E., Forbes, W. P.

Volltext

Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus‐infected patients with decompensated liver disease von Lawitz, E., Poordad, F., Gutierrez, J. A., Kakuda, T. N., Picchio, G., Beets, G., Vandevoorde, A., Van Remoortere, P., Jacquemyn, B., Luo, D., Ouwerkerk‐Mahadevan, S., Vijgen, L., Van Eygen, V., Beumont, M.

Volltext

Screening for hepatitis B in chemotherapy patients: survey of current oncology practices von TRAN, T. T., RAKOSKI, M. O., MARTIN, P., POORDAD, F.

Volltext

A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C von Jacobson, I. M., Pawlotsky, J.-M., Afdhal, N. H., Dusheiko, G. M., Forns, X., Jensen, D. M., Poordad, F., Schulz, J.

Volltext

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B von Gish, R. G., Chang, T.-T., Lai, C.-L., De Man, R., Gadano, A., Poordad, F., Yang, J., Brett-Smith, H., Tamez, R.

Volltext

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients von Dubinsky, Marla C, Vasiliauskas, Eric A, Singh, Hardeep, Abreu, Maria T, Papadakis, Kostas A, Tran, Tram, Martin, Paul, Vierling, John M, Geller, Stephen A, Targan, Stephan R, Poordad, Fred F

Volltext

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation von Yao, Francis Y., Osorio, Robert W., Roberts, John P., Poordad, Fred F., Briceno, Marjorie N., Garcia‐Kennedy, Richard, Gish, Robert R.

Volltext

Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV–HIV Coinfected Liver Transplant Recipients von Terrault, N., Reddy, K. R., Poordad, F., Curry, M., Schiano, T., Johl, J., Shaikh, O., Dove, L., Shetty, K., Millis, M., Schiff, E., Regenstein, F., Barnes, D., Barin, B., Peters, M., Roland, M., Stock, P.

Volltext